SuperSeed Capital Limited
08 September 2026
SUPERSEED CAPITAL LIMITED
(the "Company")
RELATED PARTY TRANSACTIONS
SuperSeed Capital Limited, a company established as a venture capital fund of funds for early-stage AI/SaaS companies, announces unaudited results for Q2 2026 and the six-months ended 30 June 2026. The Company invests in technology-led innovation, primarily through funds managed by SuperSeed Ventures LLP (the "Investment Manager"). The Company's principal investment to date is in SuperSeed II LP (the "Fund").
Further to the announcement made on 13 February 2026, the Company is pleased to announce it has amended the loan facility, for the issue of convertible loan notes (the "Convertible Loan Notes") to the Investment Manager, such that the aggregate principal amount of the Notes outstanding at any time has been increased from £400,000 to £500,000. All other terms and conditions of the Convertible Loan Note instrument remain unchanged.
As and when issued in the future, the proceeds of the Convertible Loan Notes shall continue to be used to fund the Company's short-term working capital and capital expenditure requirements.
The Investment Manager is a related party of the Company pursuant to the rules of the Aquis Stock Exchange. The independent directors of the Company, having exercised reasonable care, skill and diligence believe that the increase in the aggregate principal amount of the Convertible Loan Notes is fair and reasonable as far as the shareholders of the Company are concerned.
For more information, please contact:
|
SuperSeed Capital Limited |
+44(0) 203 405 3060 |
|
Mads Jensen, Investment Manager |
|
|
|
|
|
VSA Capital - AQSE Corporate Adviser and Broker |
+44(0) 203 005 5000 |
|
Corporate Finance: Andrew Raca / Sam Gurung |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.